Explore Tools Publish Peer Review CV+

/Complement inhibitors eculizumab and ravulizumab in the treatment of generalized myasthenia gravis (gMG)

Articles (10)

About Privacy Terms

Copyright © 2026. AllSci Corp. All rights reserved.